Tag: Umbralisib

Diffuse large B-cell lymphoma

Click the tags to see associated articles and topics

View Article Details

D'Angelo Describes Innovative Combos Designed to Produce Durable Activity in Relapsed ...

Added to Collection on: 2021-03-09 20:15:00

Tags for this article:

Antineoplastic drugs

Rituximab

Tumors of the hematopoietic and lymphoid tissues

P110α

Click the tags to see associated articles and topics

View Article Details

TG Therapeutics Completes Rolling Submission of Biologics License Application to the US Food ...

Added to Collection on: 2021-03-29 11:37:30

Tags for this article:

P110α

Click the tags to see associated articles and topics

View Article Details

TG Therapeutics completes FDA filing for Roche challenger in CLL - - Pharmaphorum

Added to Collection on: 2021-03-30 11:11:28

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

AACR: In redemption of the PI3K drug class, Bayer's Aliqopa leaps ahead of Gilead's Zydelig in ...

Added to Collection on: 2021-04-10 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details

UNITY-NHL Trial in R/R FL and MZL

Added to Collection on: 2021-05-27 14:26:15

Tags for this article:

Marginal zone B-cell lymphoma

Click the tags to see associated articles and topics

View Article Details

Longer-Term Data for Axicabtagene Ciloleucel in Relapsed/Refractory Follicular Lymphoma Show ...

Added to Collection on: 2021-06-22 15:11:15

Tags for this article:

Axicabtagene ciloleucel

Lymphoma

Kite Pharma

Click the tags to see associated articles and topics

View Article Details

TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment | BioSpace

Added to Collection on: 2022-04-15 18:58:23

Tags for this article:

Food and Drug Administration

Antineoplastic drugs

Accelerated approval

Ibrutinib

ublituximab

TG THERAPEUTICS

Click the tags to see associated articles and topics

View Article Details

TG Therapeutics: Ublituximab Could Achieve $1 Billion In Annual Sales By Year-End 2024

Added to Collection on: 2022-12-15 19:19:10

Tags for this article:

Health

Breakthrough therapy

Monoclonal antibodies

Food and Drug Administration

CD20

Diffuse large B-cell lymphoma

ublituximab

Click the tags to see associated articles and topics

View Article Details

Regeneron's bispecific lymphoma antibody odronextamab wins FDA priority review

Added to Collection on: 2023-09-30 00:33:25

Tags for this article:

Regeneron Pharmaceuticals

Food and Drug Administration

Prescription Drug User Fee Act

B-cell maturation antigen

Pembrolizumab